MCM
INMB icon

MAI Capital Management’s INmune Bio INMB Stock Holding History

MAI Capital Management’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,271
Closed -$4.83K – 3364
2026
Q1 		$4.83K Sell
4,271
-204
-5% -$291 ﹤0.01% 3532
2025
Q4 		$6.98K Sell
4,475
-3,318
-43% -$5.92K ﹤0.01% 2992
2025
Q3 		$16.1K Sell
7,793
-40,445
-84% -$92.6K ﹤0.01% 2508
2025
Q2 		$111K Sell
48,238
-58,559
-55% -$430K ﹤0.01% 1430
2025
Q1 		$834K Buy
106,797
+6,030
+6% +$47.9K 0.01% 677
2024
Q4 		$471K Sell
100,767
-59,991
-37% -$313K ﹤0.01% 865
2024
Q3 		$866K Buy
160,758
+176
+0.1% +$1.25K 0.01% 597
2024
Q2 		$1.42M Sell
160,582
-20,828
-11% -$205K 0.01% 500
2024
Q1 		$2.13M Buy
181,410
+83,398
+85% +$1.01M 0.02% 392
2023
Q4 		$1.1M Buy
98,012
+602
+0.6% +$5.05K 0.01% 440
2023
Q3 		$659K Buy
97,410
+38,233
+65% +$317K 0.01% 543
2023
Q2 		$537K Buy
59,177
+39,534
+201% +$318K 0.01% 611
2023
Q1 		$127K Buy
+19,643
New +$158K ﹤0.01% 976

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAI Capital Management's INMB Position: Q2 2026 in Review

MAI Capital Management sold out of INmune Bio (INMB) in Q2 2026, closing a stake of 4,271 shares — an estimated $4.83K sold.

MAI Capital Management first reported a position in INMB in Q1 2023 and held it in 13 quarters. The position peaked at $2.13M in Q1 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • MAI Capital Management reported no remaining INmune Bio position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 4,271 INmune Bio shares in Q2 2026, an estimated $4.83K.
  • MAI Capital Management first reported a position in INmune Bio in Q1 2023 and held it in 13 quarters.
  • MAI Capital Management's INmune Bio position peaked at $2.13M in Q1 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.